428 related articles for article (PubMed ID: 12759885)
1. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885
[TBL] [Abstract][Full Text] [Related]
2. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Metabolism; 2004 Apr; 53(4):414-22. PubMed ID: 15045685
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Osei K; Gaillard T; Schuster D
Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
5. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Osei K; Gaillard T; Schuster DP
Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
[TBL] [Abstract][Full Text] [Related]
6. History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes.
Osei K; Gaillard TR; Schuster DP
Diabetes Care; 1998 Aug; 21(8):1250-7. PubMed ID: 9702429
[TBL] [Abstract][Full Text] [Related]
7. Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes.
Go EH; Kyriakidou-Himonas M; Berelowitz M
Diabetes Metab Res Rev; 2004; 20(3):225-31. PubMed ID: 15133754
[TBL] [Abstract][Full Text] [Related]
8. The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.
Schuster D; Gaillard T; Rhinesmith S; Habash D; Osei K
Metabolism; 2003 Sep; 52(9):1211-7. PubMed ID: 14506629
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
Osei K; Gaillard T; Schuster D
Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
11. The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Mooradian AD; Albert SG; Bernbaum M; Plummer S
Diabetes Care; 1996 Aug; 19(8):883-4. PubMed ID: 8842609
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.
Osei K; Gaillard T; Kaplow J; Bullock M; Schuster D
Metabolism; 2004 Dec; 53(12):1552-7. PubMed ID: 15562399
[TBL] [Abstract][Full Text] [Related]
13. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
Gaillard TR; Schuster DP; Osei K
Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.
Berelowitz M; Fischette C; Cefalu W; Schade DS; Sutfin T; Kourides IA
Diabetes Care; 1994 Dec; 17(12):1460-4. PubMed ID: 7882817
[TBL] [Abstract][Full Text] [Related]
16. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
17. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
Osei K; Schuster DP
Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385
[TBL] [Abstract][Full Text] [Related]
18. Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM.
Feinglos M; Dailey G; Cefalu W; Osei K; Tayek J; Canovatchel W; Chaiken R; Kourides I
Diabetes Res Clin Pract; 2005 May; 68(2):167-75. PubMed ID: 15860246
[TBL] [Abstract][Full Text] [Related]
19. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
[TBL] [Abstract][Full Text] [Related]
20. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
Osei K; Rhinesmith S; Gaillard T; Schuster D
J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
